From March 27, 2024 to March 31, 2024, the company has repurchased 500,000 shares, representing 0.22% for CNY 9.94 million. With this, the company has completed the repurchase of 500,000 shares, representing 0.22% for CNY 9.94 million under the buyback announced on March 28, 2024.
Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
Equities
002932
CNE1000033Q7
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.8 CNY | -1.98% |
|
+3.70% | -26.86% |
1st Jan change | Capi. | |
---|---|---|
-26.86% | 550M | |
-5.32% | 12.35B | |
+98.69% | 8.55B | |
-22.31% | 6.6B | |
+6.46% | 5.88B | |
-23.61% | 3.52B | |
+5.84% | 2.55B | |
+39.18% | 2.39B | |
-7.65% | 2.33B | |
-69.05% | 2.09B |
- Stock Market
- Equities
- 002932 Stock
- News Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
- Tranche Update on Wuhan Easy Diagnosis Biomedicine Co.,Ltd.'s Equity Buyback Plan announced on March 28, 2024.